- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/19 - Particulate form, e.g. powders lyophilised
Patent holdings for IPC class A61K 9/19
Total number of patents in this class: 4844
10-year publication summary
|
368
|
392
|
485
|
502
|
469
|
473
|
453
|
384
|
350
|
141
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2716 |
63 |
| Amgen Inc. | 4362 |
57 |
| CJ BioScience, Inc. | 78 |
38 |
| Regeneron Pharmaceuticals, Inc. | 4632 |
37 |
| Novartis AG | 10341 |
35 |
| Pfizer Inc. | 3370 |
35 |
| Merck Patent GmbH | 5669 |
35 |
| Mayo Foundation for Medical Education and Research | 3354 |
32 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
29 |
| Catalent U.K. Swindon Zydis Limited | 48 |
27 |
| Merck Sharp & Dohme LLC | 3732 |
27 |
| Genentech, Inc. | 4087 |
26 |
| Board of Regents, The University of Texas System | 6062 |
25 |
| Allergan, Inc. | 2204 |
22 |
| Ferring B.V. | 722 |
22 |
| Chugai Seiyaku Kabushiki Kaisha | 1396 |
19 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 686 |
19 |
| Nitto Denko Corporation | 8470 |
17 |
| BioNTech SE | 778 |
17 |
| Abraxis BioScience, LLC | 193 |
16 |
| Other owners | 4246 |